Dr. Erkan Arpaci

A.1 E.Arpacı, T.Yetişyiğit, M.Şeker, D.Uncu, Ü.Üyetürk, B.Öksüzoğlu, U.Demirci, U.Coşkun, M.Küçüköner, A.Işıkdoğan, M.İnanç, N.Alkış , M. Özkan. Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. MedOncol. 2013 Mar;30(1):469. DOI: 10.1007/s12032-013-0469-z

A.2 E.Arpacı, S.Tokluoğlu, T.Yetişyiğit, N.Alkış. Multiple Primary Malignancies-A Retrospective Analysis at a Single Center in Turkey.Asian Pac J Cancer Prev. 2013;14(2):769-73. DOI:10.7314/APJCP.2013.14.2.769

A.3 M.Küçüköner, E.Arpacı, A.Işıkdoğan, M.Bilici, D.Uncu, B.Çetin, F.Dane, M.İnanç, S.Ekinci, A.İnal, K.Çayır, T.Yetişyiğit , N.Özdemir, MAKaplan, S.Aksoy, N.Alkış, B.Tekin, C.Eroğlu, S.Turhal, S.Büyükberber. Prognostic Analysis of Patients with Operable Gastric Cancer and Tolerability to Adjuvant Radio-Chemo-Therapy.Neoplasma. 2013;60(1):19-25. DOI: 10.4149/neo_2013_003

A.4 M.Baykara, SCÖztürk, S.Büyükberber, K.Helvacı, N.Özdemir, N.Alkış, V.Berk, D.Koca, U.Coşkun, B.Öksüzoğlu, D.Uncu, E.Arpacı, B .Öven Ustaalioğlu, U.Demirci, M.Küçüköner, G.Gököz Doğu, S.Alıcı, T.Akman, M.Özkan, Ü.Yalşıntaş Aslan, A.Gök Durnalı, M.Benekli. Clinicopathological Features in Bilateral Breast Cancer.Asian Pac J Cancer Prev. 2012;13(9):4571-5. DOI:10.7314/APJCP.2012.13.9.4571

A.5 M.Altınbaş, MEKalender, B.Öven, A.Sevinç, H.Karaca, MAKaplan, S.Alıcı, E.Arpacı, R.Yıldız, D.Uncu, C.Camcı, M.Gümüş. Weekly Topotecan for Recurrent Small Cell Lung Cancer-a Retrospective Anatolian Medical Oncology Group Study.Asian Pac J Cancer Prev. 2012;13(6):2909-12. DOI:10.7314/APJCP.2012.13.6.2909

A.6 M.Küçüköner, A.Işıkdoğan, E.Arpacı, M.Bilici, B.Çetin, F.Dane, M.İnanç, MAKaplan, K.Çayır, T.Yetişyiğit, N.Özdemir, A.İnal, S .Aksoy, N.Alkış, SBTekin, C.Eroğlu, S.Turhal, M.Benekli, S.Büyükberber. Adjuvant Chemoradiation for Gastric Cancer: Multicentric Study of the Anatolian Society of Medical Oncology.Hepatogastroenterology. 2012;59(119):2343-7. DOI: 10.5754/hge11709

A.7 T.Yetişyiğit, N.Babacan, Y.Ürün, ESŞeber, Ş.Cihan, E.Arpacı, N.Yıldırım, S.Aksoy, B.Budakoğlu, N.Zengin, B.Öksüzoğlu, B.Çiçek Yalçın, N.Applause. Predictors of Outcome in Patients with Advanced Nonseminomatous Germ Cell Testicular Tumors. Asian Pac J Cancer Prev. 2014;15(2):831-5. DOI: 10.7314/APJCP.2014.15.2.831

A.8 T.Yetişyiğit, E.Arpacı, ESŞeber, M.Küçüköner, FTKöş, Ö.Uysal Sönmez, S.Alıcı, T.Akman, B.Aktaş, R.Yıldız, Y.Günaydın, M.İnanç, U. Demirci, N.Alkış, M.Gümüş. Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev. 2013;14(9):5185-8. DOI: 10.7314/APJCP.2013.14.9.5185

A.9 T.Yetişyiğit, E.Arpacı, ESŞeber, M.Küçüköner, FTKöş, Ö.Uysal Sönmez, S.Alıcı, T.Akman, B.Aktaş, R.Yıldız, Y.Günaydın, M.İnanç, U. Demirci, İ.Öztop, A.Işıkdoğan, A.Sevinç, D.Uncu, N.Alkış, B.Öksüzoğlu, A.Gök Durnalı, U.Yılmaz, M.Gümüş. Clinical and pathological features of patients with resected synovial sarcoma: A multicenter retrospective analysis of the Anatolian Society of Medical Oncology.J Cancer Res Ther. 2014 Jan-Mar;10(1):73-8. DOI: 10.4103/0973-1482.131381

A.10 AOKaya, U.Coşkun, M.Gümüş, F.Dane, M.Özkan, A.Işıkdoğan, N.Alkış, S.Büyükberber, F.Yumuk, B.Budakoğlu, U.Demirci, V.Berk, A. .Bilici, A.İnal, E.Arpacı, M.Benekli. The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens. J Chemother. 2012 Aug;24(4):217-20. DOI: 10.1179/1973947812Y.0000000020.

A.11 H.Karaca, Ç.Geredeli, MAKaplan, U.Demirci, S.Alıcı, M.Artaç, A.Işıkdoğan, M.Benekli, O.Balakan, E.Arpacı, B.Budakoğlu, D.Uncu, T .Güler, V.Berk, M.Özkan. Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer: A Multicentric Experience. UHOD-International Journal of Hematology-Oncology 2013; 23(1): 1-6. DOI: 10.4999/uhod.12009

A.12 F.Paksoy Türköz, S.Tokluoğlu, A.Gök Durnalı, A.Ulaş, E.Arpacı, T.Yetişyiğit, G.Çelenkoğlu, N.Alkış. Cancer Evaluation in Geriatric Population: A Single Institution Experience. UHOD-International Journal of Hematology-Oncology 2013; 23(1): 28-33. DOI: 10.4999/uhod.11028

A.13 E.Arpacı, FTKöş, T.Yetişyiğit, S.Ç.Irkkan, I.Pak, F.Paksoy, A.Ulaş, S.Tokluoğlu, G.Çelenkoğlu, N.Alkış. Cervical Lymph Nodal and Esophageal Metastasis In a Patient with Primary Ovarian Carcinoma: A Case Report. UHOD-International Journal of Hematology-Oncology 2011; 21(3): 188-191. DOI: 10.4999/uhod.09112

A.14 S.Alıcı, S.Büyükberber, N.Alkış, M.Benekli, M.Özkan, A.Bilici, U.Demirci, H.Karaca, E.Arpacı, M.Gümüş, M.Altınbaş, F.Dane , HM.Turk. Low-dose docetaxel/cisplatin – leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma. Asian Pac J Cancer Prev. 2013;14(1):423-7.DOI:10.7314/APJCP.2013.14.1.423

A.15 Duran AO, Karaca H, Besiroglu M, Bayoglu IV, Menekse S, Yapıcı HS, Yazilitas D, Bahceci A, Uysal M, Sevinc A, Hacibekiroglu I, Aksoy A, Tanriverdi O, Arpaci E, Inanc M, Dane F , Ozkan M. XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology. 2014;15(23):10375-9.

A.16 Ozaslan E, Aksoy A, Gumusay O, Arpaci E, Berk V. Salvage chemotherapy with weekly paclitaxel for metastatic melanoma. Asian Pac J Cancer Prev. 2015;16(6):2581

A.17 Uncu D, Bayoglu IV, Arslan UY, Kucukoner M, Artac M, Koca D, Oguz A, Demirci U, Arpaci E, Dogan M, Kucukzeybek Y, Turker I, Isikdogan A, Guler T, Zengin N.Trastuzumab- based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study. Asian Pac J Cancer Prev. 2015;16(9):4127-31.

A.18 Unal OU, Oztop I, Yasar N, Urakci Z, Ozatli T, Bozkurt O, Sevinc A, Gunaydin Y, Yapar Taskoylu B, Arpaci E, Ulas A, Kodaz H, Tonyali O, Avci N, Aksoy A, Yilmaz AU.Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO). Thoracic Cancer. 2015 Jan;6(1):85-90. doi: 10.1111/1759-7714.12150. Epub 2015 Jan 7.

A.19 Gozdas HT, Arpaci E. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma. World J Gastroenterol. 2015 Sep 21;21(35):10251-2. doi: 10.3748/wjg.v21.i35.10251.

A.20 Ozcelik M, Seker M, Eraslan E, Koca S, Yazilitas D, Ercelep O, Ozaslan E, Kaya S, Hacibekiroglu I, Menekse S, Aksoy A, Taskoylu BY, Varol U, Arpaci E, Skinas A, Oksuzoglu B , Zengin N, Gumus M, Aliustaoglu M. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Tumor Biol. 2015 Nov 10. [Epub ahead of print]

A.21 Yazıcı O, Özdemir N, Duran AO, Menekşe S, Nahit Şendur MA, Karaca H, Göksel G, Arpacı E, Hacıbekiroğlu İ, Bilgetekin İ, Kaçan T, Özkan M, Aksoy S, Aksoy A, Çokmert S, Uysal M, Elkıran ET, Çiçin İ, Büyükberber S, Zengin N. The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO. Future Oncol. 2016 Feb;12(3):343-54. doi: 10.2217/fon.15.304. Epub 2016 Jan 18.

A.21 Süner A, Aydın D, Hacıoğlu MB, Doğu GG, İmamoğlu GI, Menekşe S, Pilancı KN, Yazıcı ÖK, Koca D, Karaağaç M, Akyol M, Akman T, Ergen S, Avcı N, Kaçan T, Bozkurt O , Kefeli U, Urakçı Z, Araz M, Arpacı E, Harputlu H, Sevinç A. Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology). Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1238-43.

A.22 Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Skinas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V , Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clin Colorectal Cancer. 2016 Aug 30. pii: S1533-0028(16)30149-9. doi: 10.1016/j.clcc.2016.08.002. [Epub ahead of print]

A.23 Cicin İ, Özatlı T, Türkmen E, Özturk T, Özçelik M, Çabuk D, Gökdurnalı A, Balvan Ö, Yıldız Y, Şeker M, Özdemir N, Yapar B, Tanrıverdi Ö, Günaydin Y, Menekşe S, Öksüzoğlu B , Aksoy A, Erdogan B, Bekir Hacıoglu M, Arpaci E, Sevinç A. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas. Balkan Med J. 2016 Sep;33(5):517-524

A.24 Aksoy A, Odabas H, Kaya S, Bozkurt O, Degirmenci M, Topcu TO, Aytekin A, Arpaci E, Avci N, Pilanci KN, Cinkir HY, Bozkaya Y, Cirak Y, Gumus M. Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort. Saudi Med J. 2017 Feb;38(2):156-162. doi: 10.15537/smj.2017.2.18055
A.25 Bilir C, Yıldız İ, Bilici A, Ucar M, Berk V, Yıldız Y, Yazıcı O, İmamoğlu Gİ, Karadurmuş N, Pilancı KN, Arpacı E, Tanrıverdi Ö, Karcı E , Temiz S, Nayır E, Oktay E, Dal P, Petekkaya İ, Varım C, Cinemre H. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. Cancer Invest. 2017 Apr 21;35(4):248-255. doi: 10.1080/07357907.2017.1292518. Epub 2017 Mar 23.
A.26 Ozaslan E, Topaloglu US, Inanc M, Gokmen Erdem U, Demir H, Arpaci E, Metin Seker M, Karaagac M, Kiziltepe M, Eker B, Ozkan M. Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer. J BUON. 2017 Jul-Aug;22(4):863-868.

A.27 Inal A, Kodaz H, Odabas H, Duran AO, Seker MM, İnanc M, Elkıran ET, Gunaydın Y, Menekse S, Topcu TO, Urakcı Z, Tastekin D, Bilici M, Cihan S, Geredeli C, Sezer E , Uncu D, Arpacı E, Ozturk B, Bal O, Uysal M, Tanrıverdi O, Gumus M, Oven Ustaalioglu BB, Suner A, Cokmert S, Hacıbekiroglu İ, Aydın K, Isıkdogan A. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology). J Cancer Res Ther. 2018 Apr-Jun;14(3):578-582. doi: 10.4103/0973-1482.176417.

A.28 Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpacı E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D, Avci N , Toprak O, Ergen A, Urvay S, Bayman E, Petekkaya E, Nayir E, Paydaş S, Yavuzsen T, Senler FC, Yaren A, Barutca S, Şahinler İ, Ozyilkan O, Tanriverdi O. Perspective of Turkish Medicine Students on Cancer , Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2018 Nov 16. doi: 10.1007/s13187-018-1441-6. [Epub ahead of print]

A.29 Degirmencioglu S, Tanriverdi O, Menekse S, Dogan M, Hacıoglu B, Oktay E, Erdem D, Arpaci E, Uluc BO, Turhal S, Yilmaz M, Pilanci KN, Sakin A, Araz M, Cokmert S, Özdemir O , Sen E, Nayir E. A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG). J BUON. 2019 Jan-Feb;24(1):136-142.

A.30 Murat Sedef A, Taner Sumbul FKA, Ayberk Besen A, Hacioglu B, Gunaldi M, Nayir E, Tanriverdi O, Arpaci E, Abali H, Ozyilkan O. Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group. J BUON. 2019 Mar-Apr;24(2):650-655.

B – Papers Presented at International Scientific Meetings and Printed in Proceedings

B.1 E.Arpacı, T.Yetişyiğit, A.Ulaş, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, N.Alkış. Cure Delays at Folfox-4 Regimen (A Combination of Leucovorin and Fluorouracil with Oxaliplatin) in Patients with Colorectal Carcinoma: A Retrospective Analysis. 12th World Congress on Gastrointestinal Cancer, Barcelona, ​​Spain, 30 June-3 July 2010, Annals of Oncology. Vol 21(suppl 6), p:65 abstr P-128

B.2 E.Arpacı, Ü.Yalçıntaş Arslan, A.Ulaş, T.Yetişyiğit, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, N.Applause. A Retrospective Analysis of Patients with Gastric Cancer: A Report of A Single Institute. 12th World Congress on Gastrointestinal Cancer, Barcelona, ​​Spain, 30 June-3 July 2010, Annals of Oncology. Vol 21 (suppl 6), p:90 abstr P-219

B.3 E.Arpacı, T.Yetişyiğit, A.Ulaş, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, N.Alkış. Extranodal Non-Hodgkin’s Lymphomas: A Retrospective Analysis. 5th APOCP Conference(Asian Pacific Organization for Cancer Prevention), Istanbul, Turkey, April 2010, abstr P-245

B.4 E.Arpacı, T.Yetişyiğit, A.Ulaş, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, N.Alkış. Treatment of Metastatic and Non-metastatic Ewing Sarcoma Family of Tumors: An Experience of Single Institute. 5th APOCP Conference(Asian Pacific Organization for Cancer Prevention), Istanbul, Turkey, April 2010, abstr P-235

B.5 E.Arpacı, A.Ulaş, T.Yetişyiğit, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, N.Alkış. A Rare Case of Primary Renal Lymphoma: A Case Report. 5th APOCP Conference(Asian Pacific Organization for Cancer Prevention), Istanbul, Turkey, April 2010, abstr P-102

B.6 A.Ulaş, E.Arpacı, A.Dizman, T.Yetişyiğit, F.Paksoy, S.Tokluoğlu, A.Durnalı, G.Çelenkoğlu, Y. Güney, N.Alkış.The Clinical and Histopathological Features of Patients with Cervix Carcinoma: An Analysis of A Single Institute. A Case Report. 5th APOCP Conference(Asian Pacific Organization for Cancer Prevention), Istanbul, Turkey, April 2010, abstr P-164

B.7 E.Arpacı, G.Erdem, N.Karadurmuş, Ş.Özaydın, M.Öztürk, F.Arpacı. Triple Negative Breast Cancer: A Clinical Perspective of A Single Institute. Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), Istanbul, Turkey, December 2012, abstr P-2

B.8 A.Ulaş, E.Arpacı, F.Paksoy Türköz, A.Gök Durnalı, T.Yetişyiğit, S.Tokluoğlu, G.Çelenkoğlu, N.Alkış.Clinical Features of Adenosquamous Carcinoma of The Lung: A Single Center Experience in Turkey Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), Istanbul, Turkey, December 2012, abstr P-85

B.9 ETElkıran, MAKaplan, T.Yetişyiğit, U.Demirci, M.İnanç, M.Şeker, H.Harputluoğlu, M.Küçüköner, E.Arpacı, Ü.Yalçıntaş Arslan, H.Karaca, M.Gümüş, A. Işıkdoğan, S.Büyükberber.Malignant peritoneal mesothelioma: A retrospective multicentric study from Turkey.Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), İstanbul, Turkey, December 2012, abstr P-25

B.10 Ç.Geredeli, MAKaplan, U.Demirci, S.Alıcı, M.Artaç, A.Işıkdoğan, M.Benekli, O.Balakan, E.Arpacı, B.Budakoğlu, D.Uncu, T.Güler, V .Berk, M.Özkan.The Safety and Efficacy of Erlotinib in Previously Treated Advanced Non-small-cell Lung Cancer: Multicenter Experience. Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), Istanbul, Turkey, December 2012, abstr P-58

B.11 T.Yetişyiğit, E.Arpacı, A.Gök Durnalı, M.Küçüköner, FTKöş, Ö.Uysal Dönmez, S.Alıcı, T.Akman, R.Yıldız, Y.Günaydın, M.İnanç, U.Demirci , İ.Öztop, A.Işıkdoğan, A.Sevinç, D.Uncu, S.Şeber, N.Alkış, B.Öksüzoğlu, U.Yılmaz.The Impact of Adjuvant Chemotherapy in Patients with Resected Synovial Sarcoma: A Multicenter Retrospective Analysis. Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), Istanbul, Turkey, December 2012, abstr P-98

B.12 A.Ulaş, F.Paksoy Türköz, A.Gök Durnalı, E.Arpacı, S.Tokluoğlu, T.Yetişyiğit, G.Çelenkoğlu, N.Alkış.Second Primary Malignancies in Non-Small Cell Lung Cancer: A Single Center Experience in Turkey.Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), İstanbul, Turkey, December 2012, abstr P-86

B.13 A.Çiltaş, S.Büyükberber, R.Yıldız, E.Arpacı, B.Budakoğlu, M.Küçüköner, MAŞendur, O.Balakan, U.Kefeli, V.Berk, H.Harputluoğlu, B.Öksüzoğlu, D .Uncu, AOKaya, N.Alkış, M.Gümüş, M.Benekli, U.Coşkun. Efficacy and Toxicity Evaluation of Cisplatin+Capecitabine Chemotherapy in Locally Advanced and Metastatic Gastric Cancer Patients.Near East and Mid Asia Association of Medical Oncology Societies(1.NEMA Congress), İstanbul, Turkey, December 2012, abstr P-13

B.14 R.Yıldız, S.Büyükberber, B.Ustaalioğlu, U.Coşkun, M.Özkan, T.Çil, M.Kalender, M.Gümüş, E.Arpacı, A.Üner, M.Benekli. The Efficacy and Toxicity of Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study of Anatolian Society of Medical Oncology (ASMO). 5th APOCP Conference(Asian Pacific Organization for Cancer Prevention), Istanbul, Turkey, April 2010, abstr P-248

B.15 Ü.Yalçıntaş Arslan, FOÖnder, B.Budakoğlu, S.Tokluoğlu, E.Arpacı, Ü.Üyetürk, A.Durnalı, K.Helvacı, B.Öksüzoğlu. Affecting factors to the survival of breast cancer with brain metastasis. European Breast Cancer Conference, 24-27 March 2010. EJC SupplementsVolume 8, Issue 3, Page 203, March 2010, abstr P-491

C1. National/international books written:-

C2. Chapters in written national/international books: Clinical Oncology Handbook, 2015, Edt. Neil Molinas Mandel. Section: Malignant Mesothelioma.

D-Articles Published in National Refereed Journals

D.1 N.Alkış, E.Arpacı, Ü.Yalçıntaş Aslan. Targeted Therapies in Non-Small Cell Lung Cancer: Review.Turkey Clinics Akciğer Arşivi 2010;11:20-25.

D.2 E.Arpacı, T.Yetişyiğit, A.Ulaş, F.Paksoy, FTKöş, S.Tokluoğlu, G.Çelenkoğlu, N.Alkış. A case of intra-abdominal myofibroblastic tumor with aggressive behavior. Turkish Journal of Oncology 2010;25(1): 28-32

D.3 E.Arpacı, S.Kalayoğlu Beşışık. Hematopoietic Stem Cell Transplantation and Cytomegalovirus Infection: Changing Clinic, Diagnosis and Treatment. Istanbul Faculty of Medicine Journal 2007; 70:51-55

D.4 Ü.Yalçıntaş Arslan, E.Arpacı, S.Tokluoğlu, A.Durnalı, N.Gökbayrak, N.Applause. Gemcitabine and Paclitaxel Rescue Therapy in a Patient with Relapsed Testicular Cancer After High-Dose Treatment. Acta Oncologica Turcica 2009;42:132-135

D.5 Ece Konuk, Erkan Arpaci, Selcuk Ergen, Emre Isik, Gamze Yurdakan. Primary squamous cell carcinoma of the breast: A case report in a review of current literature. Journal of Oncological Sciences 3 (2017) 29e31

D.6 Erkan Arpacı, Selçuk Ergen. Hürthle cell thyroid carcinoma. Türkiye Clinics Medical Oncology Thyroid Cancer Special Issue. Volume issue 10- Vol 1-2017